A.I. Virtanen Institute for Molecular Sciences - News

The new facility specialises in the production of a gene therapy drug for non-muscle invasive bladder cancer.

The PhD study demonstrates the importance of multiple drug discovery approaches when searching for a drug that has a beneficial disease modifying effect on TBI outcome.

UEF's role is to develop viral vector-based gene transfer methods for rare cardiovascular diseases, drug manufacturing and testing, and to contribute to repairing faulty genes through gene surgery using the latest gene editing technology.

The lecture topics range from cultural studies, education and society to AI, environmental law, aerosols, atmosphere and neuroscience.

The research marks a significant advancement in understanding how nanoplastics might transfer in human blood and interact with biological systems.

The PhD study provided valuable new insights into the genetic and functional mechanisms contributing to cardiovascular disease.

Eloi Schmauch's doctoral research addressed factors related to ischemic heart disease, heart failure, xenotransplantation, and Pityriasis Rubra Pilaris (PRP), a rare inflammatory skin disorder.

New research sheds light on the mechanisms associating obesity with inflammation by exploring tiny membrane particles, known as extracellular vesicles, secreted by human adipocytes.

The programme integrates neuroscience, data science, innovation management, and social and legal studies across three UEF faculties.

Traffic-related ultrafine particles impair mitochondrial functions in primary human olfactory mucosa cells.